Cutaneous Oncology News

CHICAGO — A speaker at the American Society for Dermatologic Surgery Annual Meeting discussed how a multidisciplinary approach may be necessary for the treatment of in-transit melanoma.

CHICAGO — Mohs micrographic surgery showed increased overall survival compared with wide local excising in melanoma, according to a study presented at the American Society for Dermatologic Surgery Annual Meeting.

CHICAGO — The use of sentinel lymph node biopsy can reduce the recurrence of nodules and the need for complete lymph node dissection in patients with melanoma, according to a speaker here.

CHICAGO — Addressing post-operative complications in the lower extremities can be a difficult task that needs nuanced care, according to a speaker at the American Society for Dermatologic Surgery annual meeting.

Patients with Merkel cell carcinoma have an increased risk for developing subsequent primary solid tumors and hematologic malignancies, according to data published in JAMA Dermatology.

Survivors of cutaneous melanoma, especially those diagnosed at a young age, were at an increased risk for secondary primary cancers compared with the general population, according to a study.

A higher proportion of patients are dying from nonmelanoma skin cancer globally than melanoma, according to a press release from the European Academy of Dermatology and Venerology.

In this Healio Video Perspective, Dilraj Grewal, MD, discusses a case of melanoma-associated retinopathy in a patient recalcitrant to treatment with immunosuppressive immunomodulator agents.

The FDA approved nivolumab as adjuvant treatment of adult and pediatric patients 12 years and older with completely resected stage IIB or IIC melanoma, according to the agent’s manufacturer.

Delaying post-operative radiation therapy for the treatment of Merkel cell carcinoma beyond 8 weeks significantly increased patients’ risk for locoregional recurrence, according to a study.